Yale’s Endocrine Neoplasia Program Is Flourishing
The Yale Multidisciplinary Endocrine Neoplasia Clinic has been treating benign and malignant diseases of the thyroid, parathyroid, adrenal, and pituitary glands since 2013. The program is a collaboration between the Department of Internal Medicine’s Section of Endocrinology & Metabolism and Yale Cancer Center and Smilow Cancer Hospital.
Are Ozempic and Wegovy Safe? All About the Diabetes and Obesity Drugs
PEOPLE spoke with Ania Jastreboff M.D., PhD., an obesity medicine physician scientist at Yale University to better understand the drugs and correct common misconceptions about obesity By Sheila Cosgrove Baylis Published on January 24, 2023 02:28 PMSource: People
Three Department of Internal Medicine Staff Retiring
Three Department of Internal Medicine staff are set to retire. Kathleen Marcucio from the Section of Endocrinology & Metabolism retired on December 31, 2022. Susan Ardito from the Section of Pulmonary, Critical Care & Sleep Medicine (Yale-PCCSM), and Elizabeth “Beth” Porter from the Section of General Internal Medicine retire in January 2023.
Weight-loss drugs are a milestone for the obese but expose health inequity
Designed for diabetes but used for obesity at higher doses, the medications induce loss of 15 to 22 percent of body weight on average — more than enough to significantly reduce cardiovascular and other health risks. That makes them far superior to old-style diet pills that delivered smaller benefits along with nasty side effects such as high blood pressure and loose stools.Source: Washington Post
Eight Yale Faculty Take Home Awards at the 2022 Yale Life Sciences Pitchfest
The 2022 Yale Life Science Pitchfest held on December 8, 2022 featured 31 Yale faculty innovators presenting breakthrough research projects in therapeutics, medical devices, and digital health to a crowd of over 325 people from 120+ companies, including 14 industry judges.Source: Yale Ventures
What obesity is not, however, is a behavioral disorder. “Just as people with diabetes cannot will their blood sugars to be normal, people with obesity cannot will their bodies to carry less fat,” says Ania Jastreboff, director of weight management and obesity prevention at Yale Stress Center and lead investigator of the tirzepatide trial. Yet this attitude of weight loss as a matter of will has pervaded culture and the thinking of many physicians.Source: Proto